Redeye maintains its base case of SEK 205 per share, at this time. Medicover delivered impressive results for Q1: revenues, EBITDA and EBIT were above our expectations. We are bracing ourselves for an even better Q2.
ANNONS
Redeye maintains its base case of SEK 205 per share, at this time. Medicover delivered impressive results for Q1: revenues, EBITDA and EBIT were above our expectations. We are bracing ourselves for an even better Q2.